← Back
Data updated: Mar 29, 2026
GENUS
OncologyMetabolic
Generics
GENUS is a generic drug manufacturer focused on Oncology, Metabolic. Key products include POKONZA.
1943
Since
20
Drugs
-
Trials
237
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
NYSTATIN 2026-02-05
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 81%
0 drugs Phase 3: 1 Phase 2: 6 Phase 1: 10
Metabolic 19%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (8)
Discontinued (12)
CHLORPROMAZINE HYDROCHLORIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN MEPERIDINE HYDROCHLORIDE POTASSIUM CHLORIDE METOCLOPRAMIDE HYDROCHLORIDE ISOSORBIDE MONONITRATE ISONIAZID CARISOPRODOL AND ASPIRIN TIVORBEX SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE CLEMASTINE FUMARATE HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%
Company Info
- First Approval
- 1943-03-23
- Latest
- 2025-12-22
- Applications
- 24